These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11730815)

  • 1. Hormone replacement therapy and endothelial function. Results of a randomized controlled trial in healthy postmenopausal women.
    de Kleijn MJ; Wilmink HW; Bots ML; Bak AA; van der Schouw YT; Planellas J; Engelen S; Banga JD; Grobbee DE
    Atherosclerosis; 2001 Dec; 159(2):357-65. PubMed ID: 11730815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with hormone replacement therapy lowers remnant lipoprotein particles in healthy postmenopausal women: results from a randomized trial.
    Ossewaarde ME; Dallinga-Thie GM; Bots ML; van der Schouw YT; Rabelink TJ; Grobbee DE; Westerveld HT
    Eur J Clin Invest; 2003 May; 33(5):376-82. PubMed ID: 12713450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the beneficial effect of HRT on endothelial function depend on lipid changes.
    Ossewaarde ME; Bots ML; van der Schouw YT; de Kleijn MJ; Wilmink HW; Bak AA; Planellas J; Banga JD; Grobbee DE
    Maturitas; 2003 May; 45(1):47-54. PubMed ID: 12753943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different effect of hormone replacement therapy, DHEAS and tibolone on endothelial function in postmenopausal women with increased cardiovascular risk.
    Silvestri A; Gambacciani M; Vitale C; Monteleone P; Ciaponi M; Fini M; Genazzani AR; Mercuro G; Rosano GM
    Maturitas; 2005 Apr; 50(4):305-11. PubMed ID: 15780531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of tibolone and continuous combined conjugated equine oestrogens plus medroxyprogesterone acetate on progression of carotid intima-media thickness: the Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study.
    Bots ML; Evans GW; Riley W; McBride KH; Paskett ED; Helmond FA; Grobbee DE;
    Eur Heart J; 2006 Mar; 27(6):746-55. PubMed ID: 16415304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of tibolone and continuous combined hormone therapy on mammographic breast density and breast histochemical markers in postmenopausal women.
    Valdivia I; Campodónico I; Tapia A; Capetillo M; Espinoza A; Lavín P
    Fertil Steril; 2004 Mar; 81(3):617-23. PubMed ID: 15037411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive function variations in postmenopausal women treated with continuous, combined HRT or tibolone. A comparison.
    Pan HA; Wang ST; Pai MC; Chen CH; Wu MH; Huang KE
    J Reprod Med; 2003 May; 48(5):375-80. PubMed ID: 12815913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, open-label study of conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone: effects on symptom control, bleeding pattern, lipid profile and tolerability.
    Baracat EC; Barbosa IC; Giordano MG; Haidar MA; Marinho RM; Menegocci JC; Morais KM; Tomaz G; Wehba S
    Climacteric; 2002 Mar; 5(1):60-9. PubMed ID: 11974560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of continuous combined hormone therapy and tibolone on body composition in postmenopausal women.
    Ziaei S; Moaya M; Faghihzadeh S
    Climacteric; 2010 Jun; 13(3):249-53. PubMed ID: 19848555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of hormone replacement therapy and tibolone on serum leptin levels in postmenopausal women.
    Lambrinoudaki IV; Christodoulakos GE; Panoulis CP; Rizos DA; Dendrinos SG; Liakakos T; Augoulea AD; Creatsas GC
    Maturitas; 2004 Jun; 48(2):107-13. PubMed ID: 15172084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women.
    Ziaei S; Moghasemi M; Faghihzadeh S
    Climacteric; 2010 Apr; 13(2):147-56. PubMed ID: 19731119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow resistance in carotid and middle cerebral arteries in postmenopausal women: a comparative study of tibolone and continuous combined hormone replacement therapy.
    Pan HA; Wang ST; Chen CH; Pai MC; Wu MH; Huang KE
    Climacteric; 2002 Sep; 5(3):259-65. PubMed ID: 12419084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic impact of Tibolone compared with Continuous-Combined Hormone Replacement Therapy in the management of climacteric symptoms in postmenopausal women.
    Diaby V; Perreault S; Lachaine J
    Maturitas; 2007 Oct; 58(2):138-49. PubMed ID: 17870259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term tibolone does not interfere with endothelial function: a double-blinded, randomized, controlled trial.
    Celani MF; Hurtado R; Brandão AH; Maciel da Fonseca AM; Geber S
    Climacteric; 2016 Jun; 19(3):299-302. PubMed ID: 27031181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect on sexual life--a comparison between tibolone and continuous combined conjugated equine estrogens and medroxyprogesterone acetate.
    Uygur D; Yeşildaglar N; Erkaya S
    Gynecol Endocrinol; 2005 Apr; 20(4):209-12. PubMed ID: 16019363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone replacement therapy in women with epilepsy: a randomized, double-blind, placebo-controlled study.
    Harden CL; Herzog AG; Nikolov BG; Koppel BS; Christos PJ; Fowler K; Labar DR; Hauser WA
    Epilepsia; 2006 Sep; 47(9):1447-51. PubMed ID: 16981859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of tibolone and continuous combined conjugated equine estrogen/medroxyprogesterone acetate on the endometrium and vaginal bleeding: results of the OPAL study.
    Langer RD; Landgren BM; Rymer J; Helmond FA;
    Am J Obstet Gynecol; 2006 Nov; 195(5):1320-7. PubMed ID: 16875644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tibolone and conventional hormone replacement therapies on arterial and hepatic cholesterol accumulation and on circulating endothelin-1, vascular cell adhesion molecule-1, and E-selectin in surgically menopausal monkeys.
    Register TC; Wagner JD; Zhang L; Hall J; Clarkson TB
    Menopause; 2002; 9(6):411-21. PubMed ID: 12439100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1995 Jan; 273(3):199-208. PubMed ID: 7807658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of medroxyprogesterone acetate on endothelium-dependent vasodilation in postmenopausal women receiving estrogen.
    Wakatsuki A; Okatani Y; Ikenoue N; Fukaya T
    Circulation; 2001 Oct; 104(15):1773-8. PubMed ID: 11591613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.